-- Roche Names O’Day Pharma Head as Soriot Becomes AstraZeneca CEO
-- B y   T h o m a s   M u l i e r
-- 2012-08-28T05:55:27Z
-- http://www.bloomberg.com/news/2012-08-28/roche-names-o-day-pharma-head-as-soriot-becomes-astrazeneca-ceo.html
Roche Holding AG (ROG)  named Daniel O’Day
head of its pharmaceuticals division to succeed Pascal Soriot,
who is leaving the Swiss drugmaker to become chief executive
officer of  AstraZeneca Plc. (AZN)   O’Day will begin the position Sept. 1, the Basel,
Switzerland-based company said today in an e-mailed  statement .
Roland Diggelmann will succeed O’Day as head of diagnostics,
Roche said.  Diggelmann is currently head of the Asia-Pacific region for
the diagnostics unit.  To contact the reporter on this story:
Thomas Mulier in Geneva at 
 tmulier@bloomberg.net   To contact the editor responsible for this story:
David Risser at 
 drisser@bloomberg.net  